Abstract
This study sought to evaluate whether representative abnormalities can be identified by first-pass perfusion (FPP) studies in patients with Churg-Strauss Syndrome (CSS), a rare disease characterized by small-vessel vasculitis. Seven patients with CSS (3 men, 4 women; mean age 55 ± 7 years) were investigated. Echocardiography was performed in all patients and coronary angiography in 5 patients. Magnetic resonance imaging (MRI) was performed with a 1.5 T whole body scanner in all patients. Functional cardiac imaging, T2-weighted turbo inversion recovery magnitude images, and T2-weighted turbo spin echo sequences with fat saturation were also performed. Cardiac viability was assessed by myocardial FPP imaging at rest and by delayed contrast enhancement (DCE) images. The FPP was abnormal in 5 of the 7 CSS patients. The abnormality was localized in the subendocardium of the left ventricle, particularly in areas of myocardial inflammatory edema. All patients showed subendocardial DCE abnormalities in the left ventricle, and 2 patients also in the right ventricle. The localization was typically subendocardial. This study describes a myocardial FPP deficit at rest in patients with CSS. The deficit is localized in areas of inflammatory myocardial edema. This diagnostic technique and image evaluation is simple, quick, and harmless. Due to the rarity of CSS, further studies are necessary to evaluate the impact of these findings.
Similar content being viewed by others
References
Laddis T, Manning WJ, Danias PG (2001) Cardiac MRI for assessment of myocardial perfusion: current status and future perspectives. J Nucl Cardiol 8:207–214. doi:10.1067/mnc.2001.112539
Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR (1991) First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18:959–965
Barmeyer AA, Stork A, Muellerleile K, Schofer AK, Tiburtius C, Koester R et al (2008) Comparison of quantitative coronary angiography and first-pass perfusion magnetic resonance imaging for the detection of an impaired coronary perfusion in nonsevere coronary stenosis. J Magn Reson Imaging 27:1005–1011. doi:10.1002/jmri.21341
Canyigit M, Turkbey B, Hazirolan T, Peynircioglu B, Aytemir K (2008) Magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging. J Comput Assist Tomogr 32:274–275. doi:10.1097/RCT.0b013e318074c5b7
Su MY, Yang KC, Wu CC, Wu YW, Yu HY, Tseng RY et al (2007) First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla. J Cardiovasc Magn Reson 9:633–644. doi:10.1080/10976640601093661
Arai AE (2000) Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 11:383–398. doi:10.1097/00002142-200012000-00007
Marcu CB, Beek AM, van Rossum AC (2006) Clinical applications of cardiovascular magnetic resonance imaging. CMAJ 175:911–917. doi:10.1503/cmaj.060566
Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L et al (2008) Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 10:18. doi:10.1186/1532-429X-10-18
Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1–27. doi:10.1097/00005792-197501000-00001
Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117:39–50. doi:10.1016/j.amjmed.2004.02.030
Hasley PB, Follansbee WP, Coulehan JL (1990) Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 120:996–999. doi:10.1016/0002-8703(90)90227-O
Schwab J, Zahn R, Bar I (2008) MR tomography presentation of endomyocardial fibrosis as an expression of cardiac involvement in Churg-Strauss syndrome. Rofo 180:55–57
Baccouche H, Yilmaz A, Alscher D, Klingel K, Val-Bernal JF, Mahrholdt H (2008) Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. Circulation 117:1745–1749. doi:10.1161/CIRCULATIONAHA.107.721738
Breuckmann K, Breuckmann F, Nassenstein K, Wieneke H, Barkhausen J, Erbel R (2007) MR imaging of endomyocardial fibrosis representing cardiac involvement in Churg-Strauss syndrome. Herz 32:71–72. doi:10.1007/s00059-007-2952-9
Alter P, Maisch B (2006) Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol 108:112–113. doi:10.1016/j.ijcard.2005.02.019
Wassmuth R, Göbel U, Natusch A, Schneider W, Kettritz R, Dietz R et al (2008) Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss Syndrome. J Card Fail 14:856–860. doi:10.1016/j.cardfail.2008.07.227
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100
Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG et al (2005) Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 237:75–82. doi:10.1148/radiol.2371041322
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542. doi:10.1161/hc0402.102975
Frustaci A, Gentiloni N, Chimenti C, Natale L, Gasbarrini G, Maseri A (1998) Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 114:1484–1489. doi:10.1378/chest.114.5.1484
Pennell DJ (2004) Cardiovascular magnetic resonance and the role of adenosine pharmacologic stress. Am J Cardiol 94:26D–31D. doi:10.1016/j.amjcard.2004.04.015 discussion 31D–32D
Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35. doi:10.1186/1532-429X-10-35
Kellman P, Aletras AH, Hsu LY, McVeigh ER, Arai AE (2006) T2* measurement during first-pass contrast-enhanced cardiac perfusion imaging. Magn Reson Med 56:1132–1134. doi:10.1002/mrm.21061
Di Bella EV, Parker DL, Sinusas AJ (2005) On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 54:1295–1299. doi:10.1002/mrm.20666
Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373–384
De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R et al (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654. doi:10.1016/j.jacc.2005.11.067
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hansch, A., Pfeil, A., Rzanny, R. et al. First-pass myocardial perfusion abnormalities in Churg-Strauss Syndrome with cardiac involvement. Int J Cardiovasc Imaging 25, 501–510 (2009). https://doi.org/10.1007/s10554-009-9457-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-009-9457-y